Restart Life Sciences Corp.
NMLSF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$635.44K
Close$
$0.00
97.6% downside
Current Fair Value
97.6% downsideOvervalued by 97.6% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $635,442.00 |
|---|---|
| Enterprise Value | $314,236.00 |
| Earnings per Share | $0 |
| Beta | -0.8 |
| Outstanding Shares | 50,835,341 |
Return
| Return on Equity | -15.64% |
|---|---|
| Return on Assets | -15.13% |
| Return on Invested Capital | -14.75% |
Valuation & Multiples
| P/E Ratio | -1.83 |
|---|---|
| PEG | 0.57 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.95 |
| Enterprise Value to EBIT | -0.21 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Restart Life Sciences Corp.
3 employees
CEO: Steve Loutskou
Operating internationally through its various subsidiaries, Restart Life Sciences Corp. functions as a biotechnology firm. Its core endeavors include the creation of natural therapeutic remedies tailored for individuals with autism spect...